Telomeres and telomerase in cardiovascular diseases

Genes

Volumn 7, Issue 9, 2016, Pages

  Yeh, Jih Kai ^a   Wang, Chao Yung ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Cardiovascular diseases; Cell senescence; Telomere and telomerase

Indexed keywords

TELOMERASE;

AGING; ARTICLE; CARDIAC MUSCLE CELL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL FUNCTION; CELL PROLIFERATION; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXPERIMENTAL STUDY; HEART FAILURE; HEREDITY; HUMAN; IMMUNOCOMPETENT CELL; MOLECULAR PATHOLOGY; NONHUMAN; RISK FACTOR; TELOMERE; TELOMERE LENGTH; VASCULAR SMOOTH MUSCLE CELL;

EID: 84985914318     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes7090058     Document Type: Article

References (129)

1. Mozaffarian, D.; Benjamin, E.J.; Go, A.S.; Arnett, D.K.; Blaha, M.J.; Cushman, M.; De Ferranti, S.; Després, J.; Fullerton, H.J.; Howard, V.J.; et al. Heart disease and stroke statistics-2015 update: A report from the American Heart Association. Circulation 2015, 131, E29-E322. [CrossRef] [PubMed]
2. United Nations. World Population Ageing 1950-2050. Available online: http: //www.un.org/esa/ population/publications/worldageing19502050/ (accessed on 1 May 2016).
3. Fitzpatrick, A.L.; Kronmal, R.A.; Gardner, J.P.; Psaty, B.M.; Jenny, N.S.; Tracy, R.P.;Walston, J.; Kimura, M.; Aviv, A. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am. J. Epidemiol. 2007, 165, 14-21. [CrossRef] [PubMed]
4. Brouilette, S.; Singh, R.K.; Thompson, J.R.; Goodall, A.H.; Samani, N.J. White cell telomere length and risk of premature myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 842-846. [CrossRef] [PubMed]
5. D’Mello, M.J.J.; Ross, S.A.; Briel, M.; Anand, S.S.; Gerstein, H.; Paré, G. Association between shortened leukocyte telomere length and cardiometabolic outcomes: Systematic review and meta-analysis. Circ. Cardiovasc. Genet. 2015, 8, 82-90. [CrossRef] [PubMed]
6. O’Donnell, C.J.; Demissie, S.; Kimura, M.; Levy, D.; Gardner, J.P.; White, C.; D’Agostino, R.B.; Wolf, P.A.; Polak, J.; Cupples, L.A.; et al. Leukocyte telomere length and carotid artery intimai medial thickness R the framingham heart study. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 1165-1171. [CrossRef] [PubMed]
7. Epel, E.S.; Merkin, S.S.; Cawthon, R.; Blackburn, E.H.; Adler, N.E.; Pletcher, M.J.; Seeman, T.E. The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men. Aging 2009, 1, 81-88. [CrossRef] [PubMed]
8. Burnett-Hartman, A.N.; Fitzpatrick, A.L.; Kronmal, R.A.; Psaty, B.M.; Jenny, N.S.; Bis, J.C.; Tracy, R.P.; Kimura, M.; Aviv, A. Telomere-associated polymorphisms correlate with cardiovascular disease mortality in Caucasian women: The Cardiovascular Health Study. Mech. Ageing Dev. 2012, 133, 275-281. [CrossRef] [PubMed]
9. Moyzis, R.K.; Buckingham, J.M.; Cram, L.S.; Dani,M.; Deaven, L.L.; Jones,M.D.;Meyne, J.; Ratliff, R.L.;Wu, J.R. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. USA 1988, 85, 6622-6626. [CrossRef] [PubMed]
10. Blackburn, E.H. Switching and signaling at the telomere. Cell 2001, 106, 661-673. [CrossRef]
11. De Lange, T. Shelterin: The protein complex that shapes and safeguards human telomeres. Genes Dev. 2005, 19, 2100-2110. [CrossRef] [PubMed]
12. Karlseder, J.; Smogorzewska, A.; de Lange, T. Senescence induced by altered telomere state, not telomere loss. Science 2002, 295, 2446-2449. [CrossRef] [PubMed]
13. Poss, K.D.; Wilson, L.G.; Keating, M.T. Heart regeneration in zebrafish. Science 2002, 298, 2188-2190. [CrossRef] [PubMed]
14. Richardson, G.D.; Breault, D.; Horrocks, G.; Cormack, S.; Hole, N.; Owens,W.A. Telomerase expression in the mammalian heart. FASEB J. 2012, 26, 4832-4840. [CrossRef] [PubMed]
15. Blasco, M. Telomere length, stem cells and aging. Nat. Chem. Biol. 2007, 3, 640-649. [CrossRef] [PubMed]
16. Erusalimsky, J.D.; Kurz, D.J. Cellular senescence in vivo: Its relevance in ageing and cardiovascular disease. Exp. Gerontol. 2005, 40, 634-642. [CrossRef] [PubMed]
17. Campisi, J. Cellular senescence: Putting the paradoxes in perspective. Curr. Opin. Genet. Dev. 2011, 21, 107-112. [CrossRef] [PubMed]
18. Ross, R. Atherosclerosis-An inflammatory disease. N. Engl. J. Med. 1999, 340, 115-126. [CrossRef]
19. Okuda, K.; Khan, M.Y.; Skurnick, J.; Kimura, M.; Aviv, H.; Aviv, A. Telomere attrition of the human abdominal aorta: Relationships with age and atherosclerosis. Atherosclerosis 2000, 152, 391-398. [CrossRef]
20. Chang, E.; Harley, C.B. Telomere length and replicative aging in human vascular tissues. Proc. Natl. Acad. Sci. USA 1995, 92, 11190-11194. [CrossRef] [PubMed]
21. Huzen, J.; Peeters,W.; de Boer, R.A.; Moll, F.L.;Wong, L.S.M.; Codd, V.; de Kleijn, D.P.V.; de Smet, B.J.G.L.; van Veldhuisen, D.J.; Samani, N.J.; et al. Circulating leukocyte and carotid atherosclerotic plaque telomere length: Interrelation, association with plaque characteristics, and restenosis after endarterectomy. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 1219-1225. [CrossRef] [PubMed]
22. Matthews, C.; Gorenne, I.; Scott, S.; Figg, N.; Kirkpatrick, P.; Ritchie, A.; Goddard, M.; Bennett, M. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: Effects of telomerase and oxidative stress. Circ. Res. 2006, 99, 156-164. [CrossRef] [PubMed]
23. Haendeler, J.; Hoffmann, J.; Diehl, J.F.; Vasa, M.; Spyridopoulos, I.; Zeiher, A.M.; Dimmeler, S. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ. Res. 2004, 94, 768-775. [CrossRef] [PubMed]
24. Minamino, T.; Miyauchi, H.; Yoshida, T.; Ishida, Y.; Yoshida, H.; Komuro, I. Endothelial cell senescence in human atherosclerosis: Role of telomere in endothelial dysfunction. Circulation 2002, 105, 1541-1544. [CrossRef] [PubMed]
25. Hoffmann, J.; Haendeler, J.; Aicher, A.; Rössig, L.; Vasa, M.; Zeiher, A.M.; Dimmeler, S. Aging Enhances the Sensitivity of Endothelial Cells Toward Apoptotic Stimuli Important Role of Nitric Oxide. Circ. Res. 2001, 89, 709-715. [CrossRef] [PubMed]
26. Kurz, D.J.; Hong, Y.; Trivier, E.; Huang, H.L.; Decary, S.; Zang, G.H.; Lüscher, T.F.; Erusalimsky, J.D. Fibroblast growth factor-2, but not vascular endothelial growth factor, upregulates telomerase activity in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 748-754. [CrossRef] [PubMed]
27. Vasa, M.; Breitschopf, K.; Zeiher, A.M.; Dimmeler, S. Nitric oxide activates telomerase and delays endothelial cell senescence. Circ. Res. 2000, 87, 540-542. [CrossRef] [PubMed]
28. Breitschopf, K.; Zeiher, A.M.; Dimmeler, S. Pro-atherogenic factors induce telomerase inactivation in endothelial cells through an Akt-dependent mechanism. FEBS Lett. 2001, 493, 21-25. [CrossRef]
29. Werner, C.; Hanhoun, M.; Widmann, T.; Kazakov, A.; Semenov, A.; Pöss, J.; Bauersachs, J.; Thum, T.; Pfreundschuh, M.; Müller, P.; et al. Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis. J. Am. Coll. Cardiol. 2008, 52, 470-482. [CrossRef] [PubMed]
30. Gorenne, I.; Kavurma, M.; Scott, S.; Bennett, M. Vascular smooth muscle cell senescence in atherosclerosis. Cardiovasc. Res. 2006, 72, 9-17. [CrossRef] [PubMed]
31. Minamino, T.; Kourembanas, S. Mechanisms of telomerase induction during vascular smooth muscle cell proliferation. Circ. Res. 2001, 89, 237-243. [CrossRef] [PubMed]
32. Dock, J.N.; Effros, R.B. Role of CD8 T cell replicative senescence in human aging and in HIV-mediated immunosenescence. Aging Dis. 2011, 2, 382-397. [PubMed]
33. Wu, K.; Higashi, N.; Hansen, E.R.; Lund, M.; Bang, K.; Thestrup-Pedersen, K. Telomerase activity is increased and telomere length shortened in T cells from blood of patients with atopic dermatitis and psoriasis. J. Immunol. 2000, 165, 4742-4747. [CrossRef] [PubMed]
34. Weng, N.P. Regulation of telomerase expression in human lymphocytes. Springer Semin. Immunopathol. 2002, 24, 23-33. [CrossRef] [PubMed]
35. Savva, G.M.; Pachnio, A.; Kaul, B.; Morgan, K.; Huppert, F.A.; Brayne, C.; Moss, P.A.H. Cytomegalovirus infection is associated with increased mortality in the older population. Aging Cell 2013, 12, 381-387. [CrossRef] [PubMed]
36. Spyridopoulos, I.; Hoffmann, J.; Aicher, A.; Brümmendorf, T.H.; Doerr, H.W.; Zeiher, A.M.; Dimmeler, S. Accelerated telomere shortening in leukocyte subpopulations of patients with coronary heart disease: Role of cytomegalovirus seropositivity. Circulation 2009, 120, 1364-1372. [CrossRef] [PubMed]
37. Hoffmann, J.; Shmeleva, E.V.; Boag, S.E.; Fiser, K.; Bagnall, A.; Murali, S.; Dimmick, I.; Pircher, H.; Martin-Ruiz, C.; Egred, M.; et al. Myocardial ischemia and reperfusion leads to transient CD8 immune deficiency and accelerated immunosenescence in CMV-seropositive patients. Circ. Res. 2015, 116, 87-98. [CrossRef] [PubMed]
38. Shmeleva, E.V.; Boag, S.E.; Murali, S.; Bennaceur, K.; Das, R.; Egred, M.; Purcell, I.; Edwards, R.; Todryk, S.; Spyridopoulos, I. Differences in immune responses between CMV-seronegative and -seropositive patients with myocardial ischemia and reperfusion. Immun. Inflamm. Dis. 2015, 3, 56-70. [CrossRef] [PubMed]
39. Franceschi, C.; Bonafè, M.; Valensin, S.; Olivieri, F.; de Luca, M.; Ottaviani, E.; de Benedictis, G. Inflamm-aging: An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000, 908, 244-254. [CrossRef] [PubMed]
40. Effros, R.B.; Dagarag, M.; Spaulding, C.; Man, J. The role of CD8+ T-cell replicative senescence in human aging. Immunol. Rev. 2005, 205, 147-157. [CrossRef] [PubMed]
41. Ostan, R.; Bucci, L.; Capri, M.; Salvioli, S.; Scurti, M.; Pini, E.; Monti, D.; Franceschi, C. Immunosenescence and immunogenetics of human longevity. Neuroimmunomodulation 2008, 15, 224-240. [CrossRef] [PubMed]
42. Jurk, D.;Wilson, C.; Passos, J.F.; Oakley, F.; Correia-Melo, C.; Greaves, L.; Saretzki, G.; Fox, C.; Lawless, C.; Anderson, R.; et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat. Commun. 2014. [CrossRef] [PubMed]
43. Poch, E.; Carbonell, P.; Franco, S.; Díez-Juan, A.; Blasco, M.A.; Andrés, V. Short telomeres protect from diet-induced atherosclerosis in apolipoprotein E-null mice. FASEB J. 2004, 18, 418-420. [CrossRef] [PubMed]
44. Leri, A.; Franco, S.; Zacheo, A.; Barlucchi, L.; Chimenti, S.; Limana, F.; Nadal-Ginard, B.; Kajstura, J.; Anversa, P.; Blasco, M.A. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J. 2003, 22, 131-139. [CrossRef] [PubMed]
45. Oh, H.; Taffet, G.E.; Youker, K.A.; Entman, M.L.; Overbeek, P.A.; Michael, L.H.; Schneider, M.D. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc. Natl. Acad. Sci. USA 2001, 98, 10308-10313. [CrossRef] [PubMed]
46. Torella, D.; Rota, M.; Nurzynska, D.; Musso, E.; Monsen, A.; Shiraishi, I.; Zias, E.; Walsh, K.; Rosenzweig, A.; Sussman, M.A.; et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ. Res. 2004, 94, 514-524. [CrossRef] [PubMed]
47. Chimenti, C.; Kajstura, J.; Torella, D.; Urbanek, K.; Heleniak, H.; Colussi, C.; Di Meglio, F.; Nadal-Ginard, B.; Frustaci, A.; Leri, A.; et al. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ. Res. 2003, 93, 604-613. [CrossRef] [PubMed]
48. Oh, H.; Wang, S.C.; Prahash, A.; Sano, M.; Moravec, C.S.; Taffet, G.E.; Michael, L.H.; Youker, K.A.; Entman, M.L.; Schneider, M.D. Telomere attrition and Chk2 activation in human heart failure. Proc. Natl. Acad. Sci. USA 2003, 100, 5378-53783. [CrossRef] [PubMed]
49. Rosenzweig, A. Medicine. Cardiac regeneration. Science 2012, 338, 1549-1550. [CrossRef] [PubMed]
50. Kajstura, J.; Rota, M.; Cappetta, D.; Ogórek, B.; Arranto, C.; Bai, Y.; Ferreira-Martins, J.; Signore, S.; Sanada, F.; Matsuda, A.; et al. Cardiomyogenesis in the aging and failing human heart. Circulation 2012, 126, 1869-1881. [CrossRef] [PubMed]
51. Fadini, G.P.; Agostini, C.; Sartore, S.; Avogaro, A. Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 2007, 194, 46-54. [CrossRef] [PubMed]
52. Kissel, C.K.; Lehmann, R.; Assmus, B.; Aicher, A.; Honold, J.; Fischer-Rasokat, U.; Heeschen, C.; Spyridopoulos, I.; Dimmeler, S.; Zeiher, A.M. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J. Am. Coll. Cardiol. 2007, 49, 2341-2349. [CrossRef] [PubMed]
53. Satoh, M.; Ishikawa, Y.; Takahashi, Y.; Itoh, T.; Minami, Y.; Nakamura, M. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis 2008, 198, 347-353. [CrossRef] [PubMed]
54. Murasawa, S.; Llevadot, J.; Silver, M.; Isner, J.M.; Losordo, D.W.; Asahara, T. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 2002, 106, 1133-1139. [CrossRef] [PubMed]
55. Wang, C.Y.; Wen, M.S.; Wang, H.W.; Hsieh, I.C.; Li, Y.; Liu, P.Y.; Lin, F.C.; Liao, J.K. Increased vascular senescence and impaired endothelial progenitor cell function mediated by mutation of circadian gene Per2. Circulation 2008, 118, 2166-2173. [CrossRef] [PubMed]
56. Butler, M.G.; Tilburt, J.; Devries, A.; Muralidhar, B.; Aue, G.; Hedges, L.; Atkinson, J.; Schwartz, H. Comparison of chromosome telomere integrity in multiple tissues from subjects at different ages. Cancer Genet. Cytogenet. 1998, 105, 138-144. [CrossRef]
57. Zou, Y.; Sfeir, A.; Gryaznov, S.M.; Shay, J.W.; Wright, W.E. Does a sentinel or a subset of short telomeres determine replicative senescence? Mol. Biol. Cell 2004, 15, 3709-3718. [CrossRef] [PubMed]
58. Hemann, M.T.; Strong, M.A.; Hao, L.Y.; Greider, C.W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001, 107, 67-77. [CrossRef]
59. Aviv, A.; Hunt, S.C.; Lin, J.; Cao, X.; Kimura, M.; Blackburn, E. Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR. Nucleic Acids Res. 2011. [CrossRef] [PubMed]
60. Slagboom, P.E.; Droog, S.; Boomsma, D.I. Genetic determination of telomere size in humans: A twin study of three age groups. Am. J. Hum. Genet. 1994, 55, 876-882. [PubMed]
61. Graakjaer, J.; Pascoe, L.; Der-Sarkissian, H.; Thomas, G.; Kolvraa, S.; Christensen, K.; Londoño-Vallejo, J.A. The relative lengths of individual telomeres are defined in the zygote and strictly maintained during life. Aging Cell 2004, 3, 97-102. [CrossRef] [PubMed]
62. Huda, N.; Tanaka, H.; Herbert, B.S.; Reed, T.; Gilley, D. Shared environmental factors associated with telomere length maintenance in elderly male twins. Aging Cell 2007, 6, 709-713. [CrossRef] [PubMed]
63. Codd, V.; Nelson, C.P.; Albrecht, E.; Mangino, M.; Deelen, J.; Buxton, J.L.; Hottenga, J.J.; Fischer, K.; Esko, T.; Surakka, I.; et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat. Genet. 2013, 45, 422-427. [CrossRef] [PubMed]
64. Mangino, M.; Hwang, S.J.; Spector, T.D.; Hunt, S.C.; Kimura, M.; Fitzpatrick, A.L.; Christiansen, L.; Petersen, I.; Elbers, C.C.; Harris, T.; et al. Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans. Hum. Mol. Genet. 2012, 21, 5385-5394. [CrossRef] [PubMed]
65. Von Zglinicki, T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 2002, 27, 339-344. [CrossRef]
66. Bekaert, S.; deMeyer, T.; Rietzschel, E.R.; de Buyzere,M.L.; de Bacquer, D.; Langlois,M.; Segers, P.; Cooman, L.; van Damme, P.; Cassiman, P.; et al. Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease. Aging Cell 2007, 6, 639-647. [CrossRef] [PubMed]
67. Valdes, A.M.; Andrew, T.; Gardner, J.P.; Kimura, M.; Oelsner, E.; Cherkas, L.F.; Aviv, A.; Spector, T.D. Obesity, cigarette smoking, and telomere length in women. Lancet 2005, 366, 662-664. [CrossRef]
68. Sampson, M.J.; Winterbone, M.S.; Hughes, J.C.; Dozio, N.; Hughes, D.A. Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care 2006, 29, 283-289. [CrossRef] [PubMed]
69. Strandberg, T.E.; Saijonmaa, O.; Fyhrquist, F.; Tilvis, R.S.; Strandberg, A.Y.; Miettinen, T.A.; Pitkälä, K.H.; Salomaa, V. Telomere length in old age and cholesterol across the life course. J. Am. Geriatr. Soc. 2011, 59, 1979-1981. [CrossRef] [PubMed]
70. Benetos, A.; Okuda, K.; Lajemi, M.; Kimura, M.; Thomas, F.; Skurnick, J.; Labat, C.; Bean, K.; Aviv, A. Telomere length as an indicator of biological aging: The gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 2001, 37, 381-385. [CrossRef] [PubMed]
71. Müezzinler, A.; Zaineddin, A.K.; Brenner, H. Body mass index and leukocyte telomere length in adults: A systematic review and meta-analysis. Obes. Rev. 2014, 15, 192-201. [CrossRef] [PubMed]
72. Cherkas, L.F.; Hunkin, J.L.; Kato, B.S.; Richards, J.B.; Gardner, J.P.; Surdulescu, G.L.; Kimura, M.; Lu, X.; Spector, T.D.; Aviv, A. The association between physical activity in leisure time and leukocyte telomere length. Arch. Intern. Med. 2008, 168, 154-158. [CrossRef] [PubMed]
73. Strandberg, T.E.; Strandberg, A.Y.; Saijonmaa, O.; Tilvis, R.S.; Pitkälä, K.H.; Fyhrquist, F. Association between alcohol consumption in healthy midlife and telomere length in older men. The Helsinki Businessmen Study. Eur. J. Epidemiol. 2012, 27, 815-822. [CrossRef] [PubMed]
74. Cherkas, L.F.; Aviv, A.; Valdes, A.M.; Hunkin, J.L.; Gardner, J.P.; Surdulescu, G.L.; Kimura, M.; Spector, T.D. The effects of social status on biological aging as measured by white-blood-cell telomere length. Aging Cell 2006, 5, 361-365. [CrossRef] [PubMed]
75. Wolkowitz, O.M.; Mellon, S.H.; Epel, E.S.; Lin, J.; Dhabhar, F.S.; Su, Y.; Reus, V.I.; Rosser, R.; Burke, H.M.; Kupferman, E.; et al. Leukocyte telomere length in major depression: Correlations with chronicity, inflammation and oxidative stress-preliminary findings. PLoS ONE 2011, 6, e17837. [CrossRef] [PubMed]
76. Comporti, M.; Signorini, C.; Leoncini, S.; Gardi, C.; Ciccoli, L.; Giardini, A.; Vecchio, D.; Arezzini, B. Ethanol-induced oxidative stress: Basic knowledge. Genes Nutr. 2010, 5, 101-109. [CrossRef] [PubMed]
77. Strandberg, T.E.; Saijonmaa, O.; Tilvis, R.S.; Pitkälä, K.H.; Strandberg, A.Y.; Miettinen, T.A.; Fyhrquist, F. Association of telomere length in older men with mortality and midlife body mass index and smoking. J. Gerontol. A. Biol. Sci. Med. Sci. 2011, 66, 815-820. [CrossRef] [PubMed]
78. Rojas, A.; Romay, S.; González, D.; Herrera, B.; Delgado, R.; Otero, K. Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products. Circ. Res. 2000, 86, E50-E54. [CrossRef] [PubMed]
79. Schmidt, A.M.; Hori, O.; Brett, J.; Yan, S.D.; Wautier, J.L.; Stern, D. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler. Thromb. 1994, 14, 1521-1528. [CrossRef] [PubMed]
80. Sano, H.; Nagai, R.; Matsumoto, K.; Horiuchi, S. Receptors for proteins modified by advanced glycation endproducts (AGE)-Their functional role in atherosclerosis. Mech. Ageing Dev. 1999, 107, 333-346. [CrossRef]
81. Chen, W.D.; Wen, M.S.; Shie, S.S.; Lo, Y.L.; Wo, H.T.; Wang, C.C.; Hsieh, I.C.; Lee, T.H.; Wang, C.Y. The circadian rhythm controls telomeres and telomerase activity. Biochem. Biophys. Res. Commun. 2014, 451, 408-414. [CrossRef] [PubMed]
82. Farzaneh-Far, R.; Lin, J.; Epel, E.S.; Harris, W.S.; Blackburn, E.H.; Whooley, M.A. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. JAMA 2010, 303, 250-257. [CrossRef] [PubMed]
83. Xu, Q.; Parks, C.G.; DeRoo, L.A.; Cawthon, R.M.; Sandler, D.P.; Chen, H. Multivitamin use and telomere length in women. Am. J. Clin. Nutr. 2009, 89, 1857-1863. [CrossRef] [PubMed]
84. Ornish, D.; Lin, J.; Daubenmier, J.; Weidner, G.; Epel, E.; Kemp, C.; Magbanua, M.J.M.; Marlin, R.; Yglecias, L.; Carroll, P.R.; Blackburn, E.H. Increased telomerase activity and comprehensive lifestyle changes: A pilot study. Lancet. Oncol. 2008, 9, 1048-1057. [CrossRef]
85. Werner, C.; Fürster, T.; Widmann, T.; Pöss, J.; Roggia, C.; Hanhoun, M.; Scharhag, J.; Büchner, N.; Meyer, T.; Kindermann,W.; et al. Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall. Circulation 2009, 120, 2438-2447. [CrossRef] [PubMed]
86. Samani, N.J.; van der Harst, P. Biological ageing and cardiovascular disease. Heart 2008, 94, 537-539. [CrossRef] [PubMed]
87. Brouilette, S.W.; Whittaker, A.; Stevens, S.E.; van der Harst, P.; Goodall, A.H.; Samani, N.J. Telomere length is shorter in healthy offspring of subjects with coronary artery disease: Support for the telomere hypothesis. Heart 2008, 94, 422-425. [CrossRef] [PubMed]
88. Brouilette, S.W.; Moore, J.S.; McMahon, A.D.; Thompson, J.R.; Ford, I.; Shepherd, J.; Packard, C.J.; Samani, N.J. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: A nested case-control study. Lancet 2007, 369, 107-114. [CrossRef]
89. Carty, C.L.; Kooperberg, C.; Liu, J.; Herndon, M.; Assimes, T.; Hou, L.; Kroenke, C.H.; LaCroix, A.Z.; Kimura, M.; Aviv, A.; et al. Leukocyte Telomere Length and Risks of Incident Coronary Heart Disease and Mortality in a Racially Diverse Population of Postmenopausal Women. Arterioscler. Thromb. Vasc. Biol. 2015, 35, 2225-2231. [CrossRef] [PubMed]
90. Ellehoj, H.; Bendix, L.; Osler, M. Leucocyte Telomere length and risk of cardiovascular disease in a cohort of 1,397 danish men and women. Cardiology 2016, 133, 173-177. [PubMed]
91. Haycock, P.C.; Heydon, E.E.; Kaptoge, S.; Butterworth, A.S.; Thompson, A.;Willeit, P. Leucocyte telomere length and risk of cardiovascular disease: Systematic review and meta-analysis. BMJ 2014. [CrossRef] [PubMed]
92. Willeit, P.; Willeit, J.; Brandstätter, A.; Ehrlenbach, S.; Mayr, A.; Gasperi, A.; Weger, S.; Oberhollenzer, F.; Reindl, M.; Kronenberg, F.; et al. Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 1649-1656. [CrossRef] [PubMed]
93. Blackburn, E.H.; Epel, E.S.; Lin, J. Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. Science 2015, 350, 1193-1198. [CrossRef] [PubMed]
94. Samani, N.J.; Boultby, R.; Butler, R.; Thompson, J.R.; Goodall, A.H. Telomere shortening in atherosclerosis. Lancet 2001, 358, 472-473. [CrossRef]
95. Behjati, M.; Hashemi, M.; Salehi, M.; Kelishadi, R. Can leukocyte telomere length (LTL) be considered as an index in application of neural network in the atherosclerosis risk stratification? Int. J. Cardiol. 2010, 144, 136-137. [CrossRef] [PubMed]
96. Calvert, P.A.; Liew, T.V.; Gorenne, I.; Clarke, M.; Costopoulos, C.; Obaid, D.R.; O’Sullivan, M.; Shapiro, L.M.; McNab, D.C.; Densem, C.G.; et al. Leukocyte telomere length is associated with high-risk plaques on virtual histology intravascular ultrasound and increased proinflammatory activity. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 2157-2164. [CrossRef] [PubMed]
97. Armstrong, E.J.; Xing, L.; Zhang, J.; Zheng, Y.; Shunk, K.A.; Yeh, R.W.; Farzaneh-Far, R.; Yu, B.; Jang, I.K. Association between leukocyte telomere length and drug-eluting stent strut coverage by optical coherence tomography. J. Am. Coll. Cardiol. 2012, 59, 2218-2219. [CrossRef] [PubMed]
98. Van der Harst, P.; van der Steege, G.; de Boer, R.A.; Voors, A.A.; Hall, A.S.; Mulder, M.J.; van Gilst, W.H.; van Veldhuisen, D.J. Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J. Am. Coll. Cardiol. 2007, 49, 1459-1464. [CrossRef] [PubMed]
99. Collerton, J.; Martin-Ruiz, C.; Kenny, A.; Barrass, K.; von Zglinicki, T.; Kirkwood, T.; Keavney, B. Telomere length is associated with left ventricular function in the oldest old: The Newcastle 85+ study. Eur. Heart J. 2007, 28, 172-176. [CrossRef] [PubMed]
100. Haver, V.G.; Mateo Leach, I.; Kjekshus, J.; Fox, J.C.; Wedel, H.; Wikstrand, J.; de Boer, R.A.; van Gilst, W.H.; McMurray, J.J.V.; van Veldhuisen, D.J.; et al. Telomere length and outcomes in ischaemic heart failure: Data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA). Eur. J. Heart Fail. 2015, 17, 313-319. [CrossRef] [PubMed]
101. Aurigemma, G.P. Diastolic heart failure-A common and lethal condition by any name. N. Engl. J. Med. 2006, 355, 308-310. [CrossRef] [PubMed]
102. Barasch, E.; Gottdiener, J.S.; Aurigemma, G.; Kitzman, D.W.; Han, J.; Kop,W.J.; Tracy, R.P. The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: The Cardiovascular Health Study. Circ. Heart Fail. 2011, 4, 733-739. [CrossRef] [PubMed]
103. Borlaug, B.A.; Paulus, W.J. Heart failure with preserved ejection fraction: Pathophysiology, diagnosis, and treatment. Eur. Heart J. 2011, 32, 670-679. [CrossRef] [PubMed]
104. Chen, C.H.; Nakayama, M.; Nevo, E.; Fetics, B.J.; Maughan,W.L.; Kass, D.A. Coupled systolic-ventricular and vascular stiffening with age: Implications for pressure regulation and cardiac reserve in the elderly. J. Am. Coll. Cardiol. 1998, 32, 1221-1227. [CrossRef]
105. Akasheva, D.U.; Plokhova, E.V.; Tkacheva, O.N.; Strazhesko, I.D.; Kruglikova, A.S.; Pykhtina, V.S.; Dudinskaya, E.N.; Skvortsov, D.A.; Egshatyan, L.V.; Brailova, N.V.; et al. Age-related changes of left ventricular diastolic function, NT-proBNP level and their association with leukocyte telomere length. Kardiologiia 2015, 55, 59-65. [CrossRef] [PubMed]
106. Panayiotou, A.G.; Nicolaides, A.N.; Griffin, M.; Tyllis, T.; Georgiou, N.; Bond, D.; Martin, R.M.; Hoppensteadt, D.; Fareed, J.; Humphries, S.E. Leukocyte telomere length is associated with measures of subclinical atherosclerosis. Atherosclerosis 2010, 211, 176-181. [CrossRef] [PubMed]
107. Zee, R.Y.L.; Castonguay, A.J.; Barton, N.S.; Ridker, P.M. Relative leukocyte telomere length and risk of incident ischemic stroke in men: A prospective, nested case-control approach. Rejuvenation Res. 2010, 13, 411-414. [CrossRef] [PubMed]
108. Raschenberger, J.; Kollerits, B.; Hammerer-Lercher, A.; Rantner, B.; Stadler, M.; Haun, M.; Klein-Weigel, P.; Fraedrich, G.; Kronenberg, F. The association of relative telomere length with symptomatic peripheral arterial disease: Results from the CAVASIC study. Atherosclerosis 2013, 229, 469-474. [CrossRef] [PubMed]
109. Chen, S.; Lin, J.; Matsuguchi, T.; Blackburn, E.; Yeh, F.; Best, L.G.; Devereux, R.B.; Lee, E.T.; Howard, B.V.; Roman, M.J.; Zhao, J. Short leukocyte telomere length predicts incidence and progression of carotid atherosclerosis in American Indians: The strong heart family study. Aging 2014, 6, 414-427. [CrossRef] [PubMed]
110. Boccardi, V.; Paolisso, G. Telomerase activation: A potential key modulator for human healthspan and longevity. Ageing Res. Rev. 2014, 15, 1-5. [CrossRef] [PubMed]
111. Baragetti, A.; Palmen, J.; Garlaschelli, K.; Grigore, L.; Pellegatta, F.; Tragni, E.; Catapano, A.L.; Humphries, S.E.; Norata, G.D.; Talmud, P.J. Telomere shortening over 6 years is associated with increased subclinical carotid vascular damage and worse cardiovascular prognosis in the general population. J. Intern. Med. 2015, 277, 478-487. [CrossRef] [PubMed]
112. Benetos, A.; Gardner, J.P.; Zureik, M.; Labat, C.; Xiaobin, L.; Adamopoulos, C.; Temmar, M.; Bean, K.E.; Thomas, F.; Aviv, A. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension 2004, 43, 182-185. [CrossRef] [PubMed]
113. Banerjee, B.; Peiris, D.N.; Koo, S.H.; Chui, P.; Lee, E.J.D.; Hande, M.P. Genomic imbalances in key ion channel genes and telomere shortening in sudden cardiac death victims. Cytogenet. Genome Res. 2008, 122, 350-355. [CrossRef] [PubMed]
114. Izikki, M.; Hoang, E.; Draskovic, I.; Mercier, O.; Lecerf, F.; Lamrani, L.; Liu,W.Y.; Guignabert, C.; Fadel, E.; Dorfmuller, P.; et al. Telomere maintenance is a critical determinant in the physiopathology of pulmonary hypertension. J. Am. Coll. Cardiol. 2015, 66, 1942-1943. [CrossRef] [PubMed]
115. Matsumoto, Y.; Adams, V.;Walther, C.; Kleinecke, C.; Brugger, P.; Linke, A.;Walther, T.; Mohr, F.W.; Schuler, G. Reduced number and function of endothelial progenitor cells in patients with aortic valve stenosis: A novel concept for valvular endothelial cell repair. Eur. Heart J. 2009, 30, 346-355. [CrossRef] [PubMed]
116. Oh, H.; Taffet, G.E.; Youker, K.A.; Entman, M.L.; Overbeek, P.A.; Michael, L.H.; Schneider, M.D. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc. Natl. Acad. Sci. USA 2001, 98, 10308-10313. [CrossRef] [PubMed]
117. Jaskelioff, M.; Muller, F.L.; Paik, J.H.; Thomas, E.; Jiang, S.; Adams, A.C.; Sahin, E.; Kost-Alimova, M.; Protopopov, A.; Cadiñanos, J.; et al. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 2011, 469, 102-106. [CrossRef] [PubMed]
118. Bär, C.; Bernardes de Jesus, B.; Serrano, R.; Tejera, A.; Ayuso, E.; Jimenez, V.; Formentini, I.; Bobadilla, M.; Mizrahi, J.; de Martino, A.; et al. Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction. Nat. Commun. 2014. [CrossRef] [PubMed]
119. Bernardes de Jesus, B.; Vera, E.; Schneeberger, K.; Tejera, A.M.; Ayuso, E.; Bosch, F.; Blasco, M.A. Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol. Med. 2012, 4, 691-704. [CrossRef] [PubMed]
120. González-Suárez, E.; Geserick, C.; Flores, J.M.; Blasco, M.A. Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice. Oncogene 2005, 24, 2256-2270. [CrossRef] [PubMed]
121. Samper, E.; Flores, J.M.; Blasco, M.A. Restoration of telomerase activity rescues chromosomal instability and premature aging in TERC-/- mice with short telomeres. EMBO Rep. 2001, 2, 800-807. [CrossRef] [PubMed]
122. Condorelli, G.; Jotti, G.S.; Pagiatakis, C. Fibroblast senescence as a therapeutic target of myocardial fibrosis. J. Am. Coll. Cardiol. 2016, 67, 2029-2031. [CrossRef] [PubMed]
123. Harley, C.B.; Liu, W.; Flom, P.L.; Raffaele, J.M. A natural product telomerase activator as part of a health maintenance program: Metabolic and cardiovascular response. Rejuvenation Res. 2013, 16, 386-395. [CrossRef] [PubMed]
124. Pernice, F.; Floccari, F.; Caccamo, C.; Belghity, N.; Mantuano, S.; Pacilè, M.E.; Romeo, A.; Nostro, L.; Barillà, A.; Crascì, E.; et al. Chromosomal damage and atherosclerosis. Aprotective effect fromsimvastatin. Eur. J. Pharmacol. 2006, 532, 223-229. [CrossRef] [PubMed]
125. Schupp, N.; Schmid, U.; Heidland, A.; Stopper, H. Rosuvastatin protects against oxidative stress and DNA damage in vitro via upregulation of glutathione synthesis. Atherosclerosis 2008, 199, 278-287. [CrossRef] [PubMed]
126. Bennaceur, K.; Atwill,M.; Al Zhrany, N.; Hoffmann, J.; Keavney, B.; Breault, D.; Richardson, G.; von Zglinicki, T.; Saretzki, G.; Spyridopoulos, I. Atorvastatin induces T cell proliferation by a telomerase reverse transcriptase (TERT) mediated mechanism. Atherosclerosis 2014, 236, 312-320. [CrossRef] [PubMed]
127. Spyridopoulos, I.; Haendeler, J.; Urbich, C.; Brummendorf, T.H.; Oh, H.; Schneider, M.D.; Zeiher, A.M.; Dimmeler, S. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 2004, 110, 3136-3142. [CrossRef] [PubMed]
128. Herbert, K.E.; Mistry, Y.; Hastings, R.; Poolman, T.; Niklason, L.; Williams, B. Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. Circ. Res. 2008, 102, 201-208. [CrossRef] [PubMed]
129. Werner, C.; Gensch, C.; Pöss, J.; Haendeler, J.; Böhm, M.; Laufs, U. Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis. Atherosclerosis 2011, 216, 23-34. [CrossRef] [PubMed]